ARS Pharmaceuticals, Inc. (SPRY)
4.275
+0.26
(+6.34%)
USD |
NASDAQ |
Oct 19, 13:20
ARS Pharmaceuticals Cash from Operations (Annual) : -170.87M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -170.87M |
| December 31, 2024 | 13.55M |
| December 31, 2023 | -59.27M |
| December 31, 2022 | -40.08M |
| Date | Value |
|---|---|
| December 31, 2021 | -17.56M |
| December 31, 2020 | -31.20M |
| December 31, 2019 | -18.90M |
| December 31, 2018 | -16.88M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Capricor Therapeutics, Inc. | -69.81M |
| Sionna Therapeutics, Inc. | -66.30M |
| Nektar Therapeutics | -208.51M |
| Ardelyx, Inc. | -42.48M |
| Kyntra Bio, Inc. | -4.82M |